Doctors released the vaccine at a press conference this morning.
Pitt researchers say it is “delivered through a patch of finger-sized microscopic needles.”
They say it “produces specific antibodies to SARS-CoV-2 in amounts deemed sufficient to neutralize the virus.”
Researchers @PittHealthSci tested a potential SARS-CoV-2 vaccine, which produced SARS-CoV-2 antibodies in mice in amounts deemed sufficient to neutralize the virus. The vaccine is given through a patch the size of a finger. https://t.co/rxYKTQ8NhO pic.twitter.com/AZzrCKN9jQ
– UPMC (@UPMCnews) April 2, 2020
A study on the potential vaccine appears in Lancet’s EBioMedicine and is the first peer-reviewed article to describe a candidate vaccine for COVID-19. Click here to view and read the report.
Pitt says they started laying the groundwork for a vaccine in previous coronavirus outbreaks. And development of this particular vaccine began in January.
Doctors say the next step is clinical trials, which should start quickly due to the nature of the pandemic. They say it doesn’t need to be frozen or refrigerated, which is beneficial for shipping worldwide.
KDKA visited their labs in February just after COVID-19 arrived in two tiny vials less than two inches tall and about a quarter inch for research.
The University of Pittsburgh facility is authorized to manage biosafety levels 1, 2 and 3. The higher the number of BSL, the more dangerous the disease.
It also means that other precautions should be taken. It’s much more than wearing rubber gloves and working under massive hoods designed to constantly move and filter air.
Researchers at the Centers for Vaccine Research work on the coronavirus, SARS and MERS, among others. In the BSL3 laboratory, they wear full protective suits. The air they breathe comes from a self-contained breathing apparatus.
For those working behind the scenes of Pittsburgh research giants like Dr. Jonas Salk, who invented the polio vaccine, these standards are second nature.
“Every day, as you suggested, we build on what we did the day before,” said researcher Theron Gilliland. “Really, if we can see a direction to follow, then we feel successful. “
Duprex knows he’s working on the giants’ shoulder.
“Because we have the history of infection biology at the University of Pittsburgh, which is really exceptional,” he says. “Viruses have been discovered here. Vaccines have been made here. “
More information on the coronavirus pandemic:
Stay with KDKA for the latest news on this developing story.